Human medicines European public assessment report (EPAR): Actraphane, insulin human (rDNA), Date of authorisation: 07/10/2002, Revision: 20, Status: Authorised

Records of data processing activity (public) for the Antimicrobials Sales and Use (ASU) platform

European Medicines Agency’s Data Protection Notice for the Antimicrobials Sales and Use platform

EVVet3 EVWeb Production – Release notes

Membership list: HMA-EMA joint Big Data Steering Group

Orphan designation: Autologous T lymphocytes containing a T-cell receptor against Epstein–Barr virus Treatment of peripheral T-cell lymphoma, 13/12/2023 Positive

Orphan designation: 2'-O, 4'-C-Methylene-P-thio-adenylyl-(3'->5')-2'-O, 4'-C-methylene-P-thioguanylyl-(3'->5')-2'-O, 4'-C-methylene-P-thio-adenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-deoxy-P-thio-guanylyl-(3'->5')-2'-deoxy-P-thio-guanylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-P-thio-adenylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-P-thio-adenylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-O, 4'-C-methy

Orphan designation: brogidirsen Treatment of Duchenne muscular dystrophy, 13/12/2023 Positive

Orphan designation: Humanised IgG1 kappa fragment antibody targeting TfR1 conjugated to P125 oligonucleotide Treatment of myotonic disorders, 22/05/2023 Positive

Orphan designation: Govorestat Treatment of Charcot-Marie-Tooth disease, 22/05/2023 Positive